Don't know how else to put this, but to be unambiguous: There is no MMSE data in the interim 12-week data release, which was done on Nov 5. And this is what the market is wondering about. And they are awaiting the full results, and whether there was another extension requested and granted. Guys, you have to handle your emotion about share price volatility (which is silly if you're a true investor) better. Biotech is volatile.
Market Data 
Markets 
AI
